Anti-Osteoporotic Activity of a Chinese Herb Salvia miltiorrhiza (Red sage)

The main aim of this study is to get information about the effect of Salvia miltiorrhiza (Red Sage Root) on the bone mineral density (BMD) affected from osteoporosis, and effectivity of ectosteric tanshinones CatK inhibitor isolated from Salvia miltiorrhiza blocked, selectively, the collagenase activity of CatK, without affecting the active site and confirmed its bone-preserving activity. Objective: The objective of this study is to develop a safe and effective herbal formulation using Salvia miltiorrhiza (red sage) for the treatment of osteoporosis, focusing on maximizing therapeutic benefits while minimizing side effects. The formulation aims to leverage the natural properties of red sage, known for its anti-inflammatory, antioxidant, and bone-regenerative properties, to promote bone health and improve bone density. Methodology: This study focuses on the development and evaluation of a complex herbal formulation using Salvia miltiorrhiza (red sage) targeted for osteoporosis treatment, with an emphasis on safety and minimal side effects, it involves the following Steps; Extraction Process, Preliminary Phytochemical Screening, Isolation of Extract, Invitro Studies, Invivo Studies & Formulation of solid Dosage form (Lep). Conclusion: Apart from dietary medications and chemical enriched medicines, herb Salvia miltiorrhiza has been found of great importance in curing osteoporosis by improving bone mineral density by 35 percent, without any side-effects.